Health utilities and willingness to pay in adult patients with coeliac disease in Hungary
-
Published:2023-04-17
Issue:9
Volume:32
Page:2503-2516
-
ISSN:0962-9343
-
Container-title:Quality of Life Research
-
language:en
-
Short-container-title:Qual Life Res
Author:
Angyal M. MercédeszORCID, Lakatos Peter L.ORCID, Jenei BalázsORCID, Brodszky ValentinORCID, Rencz FanniORCID
Abstract
Abstract
Background
Coeliac disease (CD) is a life-long food-related disorder with a global prevalence of approximately 1%. Patients with CD often experience reduced health-related quality of life that could improve with a strict adherence to a gluten-free diet (GFD).
Objectives
To obtain visual analogue scale (VAS), time trade-off (TTO) and willingness-to-pay (WTP) values amongst patients with CD.
Methods
In 2020–2021, a cross-sectional online survey was conducted amongst 312 adult CD patients in Hungary. Patients completed the Gastrointestinal Symptom Rating Scale (GSRS) and evaluated their current health and three hypothetical health state vignettes defined based on dietary adherence using VAS, conventional 10-year TTO and WTP. Multivariate regressions were used to explore the effect of patients’ demographic and clinical characteristics on utility and WTP values.
Results
Mean VAS values for current health and ‘CD with strict adherence to GFD’, ‘CD with loose adherence to GFD’ and ‘CD without GFD’ hypothetical health states were 79.69 ± 18.52, 85.36 ± 16.18, 62.44 ± 19.91 and 36.69 ± 25.83, respectively. Corresponding mean TTO utilities were: 0.90 ± 0.19, 0.91 ± 0.20, 0.87 ± 0.23 and 0.76 ± 0.29. Mean annual WTP values for returning to full health were: €845 ± 1077, €648 ± 1002, €862 ± 1135 and €1251 ± 1496. Older age at diagnosis, male sex, more severe gastrointestinal symptoms (GSRS) and having comorbidities were associated with lower VAS and TTO or higher WTP values for current own health (p < 0.05).
Conclusion
This is the first study to report TTO utilities for CD health states. Strict adherence to the GFD may result in substantial health gains in symptomatic patients. Utilities and WTP results can be used to estimate benefits of GFD in cost-utility and cost–benefit analyses.
Funder
New National Excellence Program 2020 of the Ministry of Innovation and Technology Magyar Tudományos Akadémia New National Excellence Program of the Ministry for Innovation and Technology Corvinus University of Budapest
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference83 articles.
1. Lebwohl, B., Sanders, D. S., & Green, P. H. R. (2018). Coeliac disease. Lancet, 391(10115), 70–81. 2. Singh, P., Arora, A., Strand, T. A., Leffler, D. A., Catassi, C., Green, P. H., et al. (2018). Global prevalence of celiac disease: Systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 16(6), 823–836. 3. Roberts, S. E., Morrison-Rees, S., Thapar, N., Benninga, M. A., Borrelli, O., Broekaert, I., et al. (2021). Systematic review and meta-analysis: The incidence and prevalence of paediatric coeliac disease across Europe. Alimentary Pharmacology & Therapeutics, 54(2), 109–128. 4. Jansson-Knodell, C. L., Hujoel, I. A., West, C. P., Taneja, V., Prokop, L. J., Rubio-Tapia, A., et al. (2019). Sex difference in celiac disease in undiagnosed populations: A systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 17(10), 1954–1968. 5. Lohi, S., Mustalahti, K., Kaukinen, K., Laurila, K., Collin, P., Rissanen, H., et al. (2007). Increasing prevalence of coeliac disease over time. Alimentary Pharmacology & Therapeutics, 26(9), 1217–1225.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|